Literature DB >> 15883181

The influence of phospholipid membranes on bovine calcitonin secondary structure and amyloid formation.

Steven S-S Wang1, Theresa A Good, Dawn L Rymer.   

Abstract

Calcitonin, a peptide hormone associated with medullary carcinoma of the thyroid, has the potential to form amyloid fibrils and may be a valuable model for investigating the role of peptide-membrane interactions in beta-sheet and amyloid formation. Via a new model peptide system, bovine calcitonin, we found that the exposure of peptide to phospholipid membranes altered its structure relative to the structures formed in aqueous solutions. Of particular relevance to the amyloidoses, incubation of calcitonin with cholesterol-rich and ganglioside-containing membranes resulted in significant enrichment in the beta-sheet and amyloid content of the peptide. The formation of amyloid was also accelerated in these systems. A correlation between the phospholipid-induced structural alterations and calcitonin binding affinities to phospholipid membranes was evident. Bovine calcitonin has considerably higher binding affinity for the phospholipid systems that enhanced its beta-sheet and amyloid structure. Electrostatic forces were not the governing forces behind the observed behavior, as supported by the fact that the ionic strength did not affect the peptide structures or binding affinities. A Van't Hoff analysis of the temperature-dependent peptide binding affinities indicated that binding led to an increase in enthalpy and possibly an increase in entropy of the peptide-membrane systems. Experiments with other amyloid-forming peptides such as beta-amyloid of Alzheimer's disease have also shown similar results and may indicate the need to manipulate peptide-membrane interactions in order to control amyloid formation and its associated disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15883181      PMCID: PMC2253368          DOI: 10.1110/ps.041240105

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  74 in total

Review 1.  Cholesterol-dependent aggregation of amyloid beta-protein.

Authors:  Katsuhiko Yanagisawa; Katsumi Matsuzaki
Journal:  Ann N Y Acad Sci       Date:  2002-11       Impact factor: 5.691

2.  Formation of a membrane-active form of amyloid beta-protein in raft-like model membranes.

Authors:  Atsuko Kakio; Sei-ichi Nishimoto; Yasunori Kozutsumi; Katsumi Matsuzaki
Journal:  Biochem Biophys Res Commun       Date:  2003-04-04       Impact factor: 3.575

3.  Unraveling the secrets of Alzheimer's beta-amyloid fibrils.

Authors:  Lynmarie K Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-13       Impact factor: 11.205

4.  Inhibition by Aplidine of the aggregation of the prion peptide PrP 106-126 into beta-sheet fibrils.

Authors:  Mar Pérez; Mourad Sadqi; Victor Muñoz; Jesús Avila
Journal:  Biochim Biophys Acta       Date:  2003-10-15

5.  The toxicity of the Alzheimer's beta-amyloid peptide correlates with a distinct fiber morphology.

Authors:  B Seilheimer; B Bohrmann; L Bondolfi; F Müller; D Stüber; H Döbeli
Journal:  J Struct Biol       Date:  1997-06       Impact factor: 2.867

6.  Inhibition of amyloid fibril formation of human amylin by N-alkylated amino acid and alpha-hydroxy acid residue containing peptides.

Authors:  Dirk T S Rijkers; Jo W M Höppener; George Posthuma; Cornelis J M Lips; Rob M J Liskamp
Journal:  Chemistry       Date:  2002-09-16       Impact factor: 5.236

7.  Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

Authors:  D M Walsh; A Lomakin; G B Benedek; M M Condron; D B Teplow
Journal:  J Biol Chem       Date:  1997-08-29       Impact factor: 5.157

8.  Amyloid: morphology and toxicity.

Authors:  Anders Olofsson; Johan Ostman; Erik Lundgren
Journal:  Clin Chem Lab Med       Date:  2002-12       Impact factor: 3.694

Review 9.  Peptide aggregation in neurodegenerative disease.

Authors:  Regina M Murphy
Journal:  Annu Rev Biomed Eng       Date:  2002-03-22       Impact factor: 9.590

10.  Nicotine breaks down preformed Alzheimer's beta-amyloid fibrils in vitro.

Authors:  Kenjiro Ono; Kazuhiro Hasegawa; Masahito Yamada; Hironobu Naiki
Journal:  Biol Psychiatry       Date:  2002-11-01       Impact factor: 13.382

View more
  2 in total

1.  Cytoplasmic domain of human myelin protein zero likely folded as beta-structure in compact myelin.

Authors:  Xiaoyang Luo; Deepak Sharma; Hideyo Inouye; Daniel Lee; Robin L Avila; Mario Salmona; Daniel A Kirschner
Journal:  Biophys J       Date:  2006-12-01       Impact factor: 4.033

2.  Amyloid oligomer neurotoxicity, calcium dysregulation, and lipid rafts.

Authors:  Fiorella Malchiodi-Albedi; Silvia Paradisi; Andrea Matteucci; Claudio Frank; Marco Diociaiuti
Journal:  Int J Alzheimers Dis       Date:  2011-02-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.